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Satellite cells are myogenic progenitors that reside between the 
sarcolemma and basal lamina of the muscle fiber and play a cru-
cial role in postnatal muscle growth and regeneration (for review 
see Zammit et al., 2006a). During skeletal muscle regeneration, 
these quiescent muscle precursor cells are “activated” to enter 
the cell cycle, and give rise to a transient amplifying popula-
tion of skeletal muscle progenitor cells termed myoblasts. 
Although quiescent satellite cells express the transcription fac-
tor Pax7 (Seale et al., 2000), activated satellite cells express the 
myogenic transcription factor MyoD (Zammit et al., 2006b). 
Activated satellite cells face a very important developmental 
decision to either continue to divide or differentiate into skeletal 
muscle cells that fuse with existing myofibers. Among the vari-
ous signaling pathways thought to control this important deci-
sion, the p38 mitogen-activated protein kinase (MAPK) family 
stands out as being crucial. p38 MAPK activity has been known 
for several years to be necessary to promote skeletal muscle 
differentiation (Zetser et al., 1999). Indeed, mice lacking p38-  
MAPK  display  delayed  myofiber  growth  and  maturation  in 
vivo, and proliferating skeletal muscle cells isolated from such 
mice display defective differentiation in vitro (Perdiguero et al., 
2007). p38- MAPK activity has been demonstrated to promote 
skeletal muscle differentiation by (a) enhancing dimerization 
of myogenic regulatory factors with their E protein binding 
partners (Lluís et al., 2005), (b) recruiting the SWI-SNF com-
plex to skeletal muscle differentiation genes (Simone et al., 
2004), and (c) activating the transcriptional activity of MEF2, 
which works in a positive feed-forward loop with MyoD to pro-
mote differentiation (Penn et al., 2004). In this issue, Gillespie 
et al. demonstrate that a different p38 MAPK family member, 
p38-, also plays a crucial role in regulating skeletal muscle 
differentiation. Interestingly (and surprisingly), this study indi-
cates that p38- MAPK does not promote skeletal muscle dif-
ferentiation but instead acts to block the premature induction of 
this program in activated satellite cells.
Since the discovery of MyoD (Davis et al., 1987), one of 
a family of muscle regulatory factors that both induce and   
coordinate the skeletal muscle differentiation program (for review 
see Tapscott, 2005), it has been apparent that the transcriptional 
activity of these basic helix-loop-helix (bHLH) transcription 
factors must be tightly regulated. Although MyoD is expressed 
in proliferating myoblasts, the skeletal muscle differentiation 
program is only induced in these cells after mitogen withdrawal. 
One of the first differentiation-specific transcriptional targets to 
be induced by MyoD is another muscle regulatory factor, termed 
Myogenin (Hollenberg et al., 1993), whose expression is essen-
tial to execute the differentiation program (Hasty et al., 1993; 
Nabeshima et al., 1993). The signals and transcriptional regula-
tory machinery that restrict Myogenin expression to differenti-
ating myocytes has been an area of intense scrutiny during the 
past decade. Myogenin is a direct transcriptional target of MyoD 
(Hollenberg et al., 1993), and the myogenin promoter contains 
both a high-affinity MyoD binding site (a canonical E box) and 
a low-affinity MyoD binding site (a noncanonical E box), the 
latter of which is located adjacent to a homeodomain binding 
site (Berkes et al., 2004). Interaction between MyoD and the 
homeodomain protein Pbx has been demonstrated to stabilize 
binding of MyoD to this low-affinity binding site (Berkes et al., 
2004). What factors inhibit the inappropriate induction of myo-
genin in proliferating myoblasts? Early studies by Benezra et al. 
(1990)  documented  that  expression  of  Id1—a  dominant- 
negative HLH protein that competes with MyoD for interaction 
with its obligate DNA-binding partners, the bHLH E proteins—
is down-regulated during skeletal muscle differentiation; this 
observation led to the hypothesis that members of the Id protein 
family might act to restrict MyoD activity in proliferating 
In this issue, Gillespie et al. (Gillespie et al. 2009. J. Cell 
Biol. doi:10.1083/jcb.200907037) demonstrate that the 
mitogen-activated protein kinase isoform p38- plays a 
crucial role in blocking the premature differentiation of 
satellite  cells,  a  skeletal  muscle  stem  cell  population.   
p38- puts the brakes on skeletal muscle differentiation 
by promoting the association of the transcription factor 
MyoD with the histone methyltransferase, KMT1A, which 
act together in a complex to repress the premature ex-
pression of the gene encoding the myogenic transcription 
factor Myogenin.
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p38-–null mice display increased expression of Myogenin, 
loss of Pax7 expression, and markedly defective skeletal mus-
cle differentiation in vivo (Gillespie et al., 2009). Surprisingly, 
another group did not observe either regeneration defects in   
p38-–null mice or altered differentiation of myoblasts derived 
from these animals (Ruiz-Bonilla et al., 2008), which suggests 
that mouse strain–specific genetic modifiers may alter the 
response of myoblasts to p38- deficiency. The consistent set 
of observations of Gillespie et al. (2009) make a compelling 
argument that p38- MAPK plays a crucial role in blocking the 
premature induction of Myogenin and consequent differentia-
tion of activated satellite cells. In striking contrast, satellite cells 
in p38-–null mice display increased expression of Pax7, aug-
mented proliferation, and defective differentiation (Perdiguero 
et al., 2007), which is the inverse phenotype of p38- deficiency. 
Thus, the present study by Gillespie et al. (2009), together with 
other prior studies, highlights the surprisingly distinct role for 
differing members of the p38 MAPK family in either promot-
ing or inhibiting the differentiation of activated satellite cells. It 
seems likely that the balance between p38- and p38- MAPK 
activity in activated satellite cells serves as an accelerator or 
brake, respectively, to drive the process of skeletal muscle dif-
ferentiation. Together, they resemble the conflicting interests of 
the two-headed pushmi-pullyu, who struggles to go in two oppo-
site directions simultaneously (Fig. 1; Lofting, 1920). Although 
the activity of the pro-differentiation signal p38- MAPK is 
known to be regulated during skeletal muscle differentiation   
by the cell surface Ig superfamily member Cdo (Takaesu et al.,   
2006),  the  signals  that  specifically  regulate  p38-  MAPK   
activity in proliferating myoblasts or differentiated myocytes are 
unknown. Lastly, it seems likely that p38 MAPK family mem-
bers play an additional important role during satellite cell acti-
vation, as treatment of quiescent satellite cells with SB203580, 
a p38-/ MAPK inhibitor, blocks both the proliferation and 
myoblasts by blocking interaction of MyoD with DNA (Benezra 
et al., 1990). However, because chromatin immunoprecipitation 
assays have more recently demonstrated that MyoD is indeed 
bound to various transcriptional targets, including Myogenin, in 
proliferating myoblasts (Mal and Harter, 2003; Blais et al., 2005; 
Ishibashi et al., 2005; Ohkawa et al., 2006), there must be a 
non–Id-based mechanism for restricting Myogenin expression 
to differentiated cells.
An initial clue to resolve this issue was the identification 
of the histone modification mark H3K9me3 over the myogenin 
promoter specifically in proliferating myoblasts (Mal and Harter, 
2003). This histone modification is associated with facultative 
heterochromatin and is “read” by the transcriptional corepres-
sor HP1, which in turn can interact with other heterochromatin- 
associated proteins (for review see Lomberk et al., 2006). 
Importantly, Mal demonstrated that MyoD could be isolated in 
complex with the histone methyl-transferase KMT1A (also 
known as Suv39h1), the “writer” of H3K9me3 modification, 
specifically in proliferating myoblasts but not in differentiated 
myocytes (Mal, 2006). This important observation suggested 
that differential interaction of MyoD with KMT1A in proliferat-
ing myoblasts versus differentiated myocytes may act to restrict 
transcriptional activation of target genes by MyoD to the latter.   
What signals modulate interaction of MyoD with KMT1A differ-
entially in myoblasts versus differentiated myocytes? Gillespie 
et al. (2009) demonstrate that p38- MAPK phosphorylates 
the carboxy terminus of MyoD on serines 199 and 200, leading 
to increased interaction of MyoD with KMT1A. Consistent with 
these observations, this study also demonstrates that satel-
lite cell–derived myoblasts isolated from mice lacking p38- 
MAPK display decreased KMT1A association with chromatin 
encompassing the myogenin promoter, and consequently dis-
play both accelerated expression of Myogenin and decreased 
proliferation  in  vitro.  Most  importantly,  satellite  cells  in 
Figure 1.  What’s an activated satellite cell to do? Although p38- MAPK activity simultaneously promotes the differentiation of activated satellite cells and 
inhibits their proliferation, p38- MAPK activity works in an opposing fashion to block differentiation of these cells, and instead promotes their proliferation. 
Thus, the conflicting signals of p38- versus p38- MAPK activity in activated satellite cells resemble the conflicting interests of the two headed pushmi-pullyu,   
who struggles to go in two opposite directions simultaneously (Lofting, 1920).943 A pushmi-pullyu of satellite cells • Lassar
induction of MyoD in such cells (Jones et al., 2005), and thus 
suggests that this kinase family also plays an important role in 
regulating entry of quiescent satellite cells to become a transient   
amplifying population.
Submitted: 23 November 2009
Accepted: 2 December 2009
References
Benezra, R., R.L. Davis, D. Lockshon, D.L. Turner, and H. Weintraub. 1990. The 
protein Id: a negative regulator of helix-loop-helix DNA binding proteins. 
Cell. 61:49–59. doi:10.1016/0092-8674(90)90214-Y
Berkes, C.A., D.A. Bergstrom, B.H. Penn, K.J. Seaver, P.S. Knoepfler, and 
S.J. Tapscott. 2004. Pbx marks genes for activation by MyoD indicating 
a role for a homeodomain protein in establishing myogenic potential. 
Mol. Cell. 14:465–477. doi:10.1016/S1097-2765(04)00260-6
Blais,  A.,  M.  Tsikitis,  D.  Acosta-Alvear,  R.  Sharan,  Y.  Kluger,  and  B.D. 
Dynlacht. 2005. An initial blueprint for myogenic differentiation. Genes 
Dev. 19:553–569. doi:10.1101/gad.1281105
Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single trans-
fected  cDNA  converts  fibroblasts  to  myoblasts.  Cell.  51:987–1000. 
doi:10.1016/0092-8674(87)90585-X
Gillespie, M.A., F. Le Grand, A. Scimè, S. Kuang, J. von Maltzahn, V. Seale, A. 
Cuenda, J.A. Ranish, and M.A. Rudnicki. 2009. p38-–dependent gene 
silencing restricts entry into the myogenic differentiation program. J. Cell 
Biol. 187:991–1005.
Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, 
and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice 
with a targeted mutation in the myogenin gene. Nature. 364:501–506. 
doi:10.1038/364501a0
Hollenberg, S.M., P.F. Cheng, and H. Weintraub. 1993. Use of a conditional 
MyoD transcription factor in studies of MyoD trans-activation and muscle 
determination. Proc. Natl. Acad. Sci. USA. 90:8028–8032. doi:10.1073/ 
pnas.90.17.8028
Ishibashi, J., R.L. Perry, A. Asakura, and M.A. Rudnicki. 2005. MyoD induces 
myogenic differentiation through cooperation of its NH2- and COOH-
terminal regions. J. Cell Biol. 171:471–482. doi:10.1083/jcb.200502101
Jones,  N.C.,  K.J.  Tyner,  L.  Nibarger,  H.M.  Stanley,  D.D.  Cornelison, Y.V. 
Fedorov,  and  B.B.  Olwin.  2005.  The  p38/  MAPK  functions  as  a 
molecular  switch  to  activate  the  quiescent  satellite  cell.  J.  Cell  Biol. 
169:105–116. doi:10.1083/jcb.200408066
Lluís, F., E. Ballestar, M. Suelves, M. Esteller, and P. Muñoz-Cánoves. 2005. 
E47  phosphorylation  by  p38  MAPK  promotes  MyoD/E47  associa-
tion  and  muscle-specific  gene  transcription.  EMBO  J.  24:974–984. 
doi:10.1038/sj.emboj.7600528
Lofting, H. 1920. The Story of Doctor Dolittle: Being the History of His Peculiar 
Life at Home and Astonishing Adventures in Foreign Parts. Frederick A. 
Stokes, New York. 180 pp.
Lomberk, G., L. Wallrath, and R. Urrutia. 2006. The Heterochromatin Protein 1 
family. Genome Biol. 7:228. doi:10.1186/gb-2006-7-7-228
Mal, A.K. 2006. Histone methyltransferase Suv39h1 represses MyoD-stimulated   
myogenic differentiation. EMBO J. 25:3323–3334. doi:10.1038/sj.emboj 
.7601229
Mal, A., and M.L. Harter. 2003. MyoD is functionally linked to the silencing of a 
muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. 
Acad. Sci. USA. 100:1735–1739. doi:10.1073/pnas.0437843100
Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and 
Y.  Nabeshima.  1993.  Myogenin  gene  disruption  results  in  perinatal   
lethality  because  of  severe  muscle  defect.  Nature.  364:532–535. 
doi:10.1038/364532a0
Ohkawa, Y., C.G. Marfella, and A.N. Imbalzano. 2006. Skeletal muscle specifi-
cation by myogenin and Mef2D via the SWI/SNF ATPase Brg1. EMBO 
J. 25:490–501. doi:10.1038/sj.emboj.7600943
Penn, B.H., D.A. Bergstrom, F.J. Dilworth, E. Bengal, and S.J. Tapscott. 2004. 
A MyoD-generated feed-forward circuit temporally patterns gene expres-
sion during skeletal muscle differentiation. Genes Dev. 18:2348–2353. 
doi:10.1101/gad.1234304
Perdiguero, E., V. Ruiz-Bonilla, L. Gresh, L. Hui, E. Ballestar, P. Sousa-Victor, 
B.  Baeza-Raja,  M.  Jardí, A.  Bosch-Comas,  M.  Esteller,  et  al.  2007. 
Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of 
p38alpha in abrogating myoblast proliferation. EMBO J. 26:1245–1256. 
doi:10.1038/sj.emboj.7601587
Ruiz-Bonilla, V., E. Perdiguero, L. Gresh, A.L. Serrano, M. Zamora, P. Sousa-
Victor, M. Jardí, E.F. Wagner, and P. Muñoz-Cánoves. 2008. Efficient adult 
skeletal muscle regeneration in mice deficient in p38beta, p38gamma and 
p38delta MAP kinases. Cell Cycle. 7:2208–2214.
Seale, P., L.A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, and M.A. 
Rudnicki. 2000. Pax7 is required for the specification of myogenic satel-
lite cells. Cell. 102:777–786. doi:10.1016/S0092-8674(00)00066-0
Simone, C., S.V. Forcales, D.A. Hill, A.N. Imbalzano, L. Latella, and P.L. Puri. 
2004. p38 pathway targets SWI-SNF chromatin-remodeling complex to 
muscle-specific loci. Nat. Genet. 36:738–743. doi:10.1038/ng1378
Takaesu, G., J.S. Kang, G.U. Bae, M.J. Yi, C.M. Lee, E.P. Reddy, and R.S. 
Krauss. 2006. Activation of p38/ MAPK in myogenesis via binding 
of the scaffold protein JLP to the cell surface protein Cdo. J. Cell Biol. 
175:383–388. doi:10.1083/jcb.200608031
Tapscott, S.J. 2005. The circuitry of a master switch: Myod and the regulation 
of  skeletal  muscle  gene  transcription.  Development.  132:2685–2695. 
doi:10.1242/dev.01874
Zammit, P.S., T.A. Partridge, and Z. Yablonka-Reuveni. 2006a. The skeletal mus-
cle satellite cell: the stem cell that came in from the cold. J. Histochem. 
Cytochem. 54:1177–1191. doi:10.1369/jhc.6R6995.2006
Zammit, P.S., F. Relaix, Y. Nagata, A.P. Ruiz, C.A. Collins, T.A. Partridge, and 
J.R. Beauchamp. 2006b. Pax7 and myogenic progression in skeletal mus-
cle satellite cells. J. Cell Sci. 119:1824–1832. doi:10.1242/jcs.02908
Zetser, A., E. Gredinger, and E. Bengal. 1999. p38 mitogen-activated protein 
kinase pathway promotes skeletal muscle differentiation. Participation 
of  the  Mef2c  transcription  factor.  J.  Biol.  Chem.  274:5193–5200. 
doi:10.1074/jbc.274.8.5193